» Articles » PMID: 35324747

The Other Face of Insulin-Overdose and Its Effects

Overview
Journal Toxics
Date 2022 Mar 24
PMID 35324747
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin is the most effective glycemic-lowering drug, and for people suffering from type 1 diabetes it is a life-saving drug. Its self-dosing by patients may be associated with a higher risk of overdose, both accidental and deliberate. Insulin-induced hypoglycemia causes up to 100,000 emergency department calls per year. Cases of suicide attempts using insulin have been described in the literature since its introduction into therapy, and one of the important factors in their occurrence is the very fact of chronic disease. Up to 90% of patients who go to toxicology wards overdose insulin consciously. Patients with diabetes are burdened with a 2-3 times higher risk of developing depression compared to the general population. For this reason, it is necessary to develop an effective system for detecting a predisposition to overdose, including the assessment of the first symptoms of depression in patients with diabetes. A key role is played by a risk-conscious therapeutic team, as well as education. Further post-mortem testing is also needed for material collection and storage, as well as standardization of analytical methods and interpretation of results, which would allow for more effective detection and analysis of intentional overdose-both by the patient and for criminal purposes.

Citing Articles

Insulin-Related Suicides-3 Cases.

Prahlow J, Castor M, Jones P Acad Forensic Pathol. 2024; 14(4):146-155.

PMID: 39534452 PMC: 11552034. DOI: 10.1177/19253621241272228.


Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database.

Ilie I, Vonica-Tincu A, Dobrea C, Butuca A, Frum A, Morgovan C Biomedicines. 2024; 12(10).

PMID: 39457586 PMC: 11504911. DOI: 10.3390/biomedicines12102273.


The Interrelationship between Diabetes Mellitus and Emotional Well-Being: Current Concepts and Future Prospects.

Mangoulia P, Milionis C, Vlachou E, Ilias I Healthcare (Basel). 2024; 12(14).

PMID: 39057600 PMC: 11276337. DOI: 10.3390/healthcare12141457.


Intentional Insulin Overdose and Depression in Subjects with and Without Diabetes Mellitus: A Commentary.

Gouveri E, Gkouveri A, Popovic D, Papazoglou D, Papanas N Diabetes Ther. 2024; 15(9):1845-1854.

PMID: 39046697 PMC: 11330432. DOI: 10.1007/s13300-024-01623-5.


Biochemical Toxicological Study of Insulin Overdose in Rats: A Forensic Perspective.

Bian C, He X, Wang Q, Zheng Z, Zhang Y, Xiong H Toxics. 2024; 12(1).

PMID: 38250973 PMC: 10819875. DOI: 10.3390/toxics12010017.


References
1.
Anderson L, Tamayose J, Garcia J . Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Mol Cell Endocrinol. 2017; 464:65-74. PMC: 5723243. DOI: 10.1016/j.mce.2017.06.010. View

2.
Roberge R, Martin T, Delbridge T . Intentional massive insulin overdose: recognition and management. Ann Emerg Med. 1993; 22(2):228-34. DOI: 10.1016/s0196-0644(05)80210-0. View

3.
Beaumont G . Automatism and hypoglycaemia. J Forensic Leg Med. 2007; 14(2):103-7. DOI: 10.1016/j.jcfm.2006.01.010. View

4.
Golomb B, Tenkanen L, Alikoski T, Niskanen T, Manninen V, Huttunen M . Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees. J Clin Epidemiol. 2002; 55(8):767-73. DOI: 10.1016/s0895-4356(02)00407-9. View

5.
Longo N, Wang Y, Pasquali M . Progressive decline in insulin levels in Rabson-Mendenhall syndrome. J Clin Endocrinol Metab. 1999; 84(8):2623-9. DOI: 10.1210/jcem.84.8.5902. View